Aysel Heckel

Aysel Heckel is an experienced sales leader in the biotechnology and life sciences sectors, currently serving as Vice President of Sales at Astrix since April 2024. Aysel previously led mid-market sales for North America at Benchling, achieving team success and customer advocacy during a challenging period. Prior roles include Vice President of Sales & Support at Oxford Gene Technology, where Aysel oversaw commercial operations for molecular genetics reagents, and Director of Global Clinical Solutions Sales at QIAGEN, responsible for launching clinical decision support solutions. Aysel's extensive background also includes positions at Illumina, Ingenuity Systems, and Roche Diagnostics, highlighting a strong focus on genomic technologies and market expansion. Aysel holds a Bachelor’s Degree in Biochemistry from Texas A&M University.